APIC Chapter 13 Journal Club

Slides:



Advertisements
Similar presentations
The Balance of Care Group Alternatives to Hospital MODELS OF INTEGRATED CARE Tom Bowen ORAHS 2008, Toronto, 29 July.
Advertisements

HAI Program Update Meredith Kanago, MSPH TDH Statewide CEDEP Meeting 30 April 2014.
Abstract Results continued Reference 1 McDonald LC, Coignard B, Dubberke E, et al. Recommendations for Surveillance of Clostridium difficile-Associated.
Introduction to the National Healthcare Safety Network (NHSN) Richard Rodriguez, MPH Connecticut Department of Public Health 4/9/2014 Thank you to CDC.
Clostridium Difficile (C.diff): Fast Facts. What is Clostridium difficile (C. diff)? C. diff is a bacteria that lives in the intestinal tract of about.
C. difficile Lab ID Reporting in NHSN Stanley Ostrawski RN, MS, MT(ASCP), CIC Infection Preventionist Consultant.
Dr. ABDULLAH ABDU ALMIKHLAFY Assistant professor & Head of community medicine department Presented By University of Science & Technology Sana’a – Yemen.
C. difficile Subcommittee Summary HAI Advisory Committee Nov 18, 2010 Submitted by R. Murthy, MD (Subcommittee Chair)
Progress in Diagnosing and Treating Clostridium difficile in IBD patients Alan C. Moss MD, FEBG, FACG, AGAF Associate Professor of Medicine Director of.
APIC Chapter 13 Journal Club April 15, 2015
Objectives After this session, the attendee should be able to:
Epidemiology The Basics Only… Adapted with permission from a class presentation developed by Dr. Charles Lynch – University of Iowa, Iowa City.
NHSN SSI Clarifications Janet Sullivan, Oregon SW Washington APIC Jeanne Negley, Oregon Health Policy & Research.
Preventing Transmission of C. difficile: Practice Elise Tamplin, M(ASCP), MPH, CIC Brigham & Women’s Hospital.
Preventing and Treating C.difficile Lisa Casey, M.D. Assistant Professor, UT Southwestern Medical Center TSGE / SGNA Annual Scientific Meeting September.
Entering Data into Complication fields in the CDB October 15, 2014 Maryland Department of Health and Mental Hygiene Prevention and Health Promotion Administration.
AHRQ Safety Program for Long-term Care: HAIs/CAUTI Infection Prevention: Surveillance Essentials in Preventing Health Care-Associated Infections How to.
AHRQ Safety Program for Long-term Care: HAIs/CAUTI Infection Prevention: Surveillance Essentials in Preventing Health Care-Associated Infections How to.
Hospital Based Surveillance to Estimate the Burden of Rotavirus Gastroenteritis Among European Children Younger than 5 Years of Age Johannes Foster, Alfredo.
ASSESSING THE FEASIBILITY OF ANTIBIOTIC MANAGEMENT SERVICES THROUGH PROSPECTIVE EVALUATION ABSTRACT PURPOSE: The inappropriate and unnecessary use of antibiotics.
"Epidemiological Features of Rotavirus Infection among children below 5 years old in Jordan, Rationale for Vaccine Introduction,2015" Kareman Juma`ah Al-Zain.
APIC Chapter 13 Journal Club March 16, 2015 Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults NEJM – July 30, :5 Presented.
Clostridium difficile infection (CDI) in the ICU and Clostridium difficile outcomes in the PROSPECT Main Trial Erick Duan MD FRCPC Presented at the CCCTG.
ECDC Point prevalence survey of healthcare-associated infections and antimicrobial use in acute care hospitals Forms V4.2.
Outbreak Investigation
NHSN Reporting for Critical Access Hospitals
Reducing the Risk of Clostridium difficile Infection:
Evaluating the Effectiveness of Social Work Interventions:
Antibiotics: handle with care!
March 17-20, ¥ Gaylord Palms Resort & Convention Center ¥ Orlando, FL
WHO Operational Plan for RSV Surveillance Pilot
Measuring outcomes in colorectal surgery: the nurse’s role
and brain injured patients in an inpatient rehabilitation hospital
MPRO Update MICAH Quarterly Meeting
Strategies to Reduce Antibiotic Resistance and to Improve Infection Control Robin Oliver, M.D., CPE.
Impact of the Type of Diagnostic Assay on Clostridium difficile Infection and Complication Rates in a Mandatory Reporting Program Yves Longtin, Sylvie.
PHEN Clinical Trials Rally
NYSDOH AIDS Institute Quality of Care Program eHIVQUAL
Impact of State Reporting Laws on Central Line– Associated Bloodstream Infection Rates in U.S. Adult Intensive Care Units Hangsheng Liu, Carolyn T. A.
Appraising a diagnostic test study using a critical appraisal checklist Mahilum-Tapay L, et al. New point of care Chlamydia Rapid Test – bridging the gap.
HCF (not BMC) Associated Association Indeterminate
Evaluating Sepsis Guidelines and Patient Outcomes
C. difficile Detection and the Importance of Proper Specimen Collection and Testing [Name] [Title]
Veterans with life-limiting illness: Baseline descriptors
Utilizing the Candida Score to Identify Patients at Increased Risk for
Duration of Therapy of Colony Stimulating Factors in Oncology
VFC Site Visit Questionnaire and AFIX as Tools for Quality Assessment
Michelle Charles MSN, RN Karen Vallejo MSN, RN, CIC
About the GI Flora Balance Program
Antimicrobial Therapy (Vancomycin and/or Metronidazole)
Appraising a diagnostic test study using a critical appraisal checklist Mahilum-Tapay L, et al. New point of care Chlamydia Rapid Test – bridging the gap.
Robin Nettleton MSN RN St. Luke’s Elmore, Mountain Home
HAI August 30, 2017.
HAI January 24, 2018.
HAI Sept. 25, 2017.
CNISP & CIHI MRSA infection rate comparison Preliminary results
ECDC point prevalence survey (PPS)
Aim and Key Driver Diagram
Management of Clostridium Difficile Infection
Intermountain APIC Chapter CIC training questions
Intermountain APIC Chapter CIC training questions
Clostridium difficile Update
C. Difficile Surveillance Quality Improvement Initiative Baystate Health System Anne Zawacki RN MPH CIC.
C. difficile Update Kim Vermedal, RN, MSN, CIC APIC January 25, 2019.
THE EFFECT OF BUNDLED INTERVENTIONS ON PREVENTION OF HOSPITAL ACQUIRED CLOSTRIDIUM DIFFICILE INFECTION Kaitlin M. Kendys BSN, RN DNP Student Significance.
A Quality Improvement Project to Improve the Usage of Universal Lipid Screening Guidelines at a Federally Qualified Health Center in the Southern United.
Intermountain APIC Chapter CIC training questions
C. diff Testing Stewardship
USE OF RESERVE ANTIBIOTICS IN PICU/NICU AT MP SHAH HOSPITAL DESPITE NEGATIVE CULTURES BY MIRIAM ORANG’ 5/10/2017.
UNMH’s hospital acquired C
Presentation transcript:

APIC Chapter 13 Journal Club Hannah Newman, MPH, CIC Lenox Hill Hospital

C.difficile is a leading cause of HAIs associated with hospitalizations and antibiotic use responsible for an estimated 250,000 cases, 14,000 deaths, and $5.4 billion cost annually Mandatory reported infection for CMS participating hospitals as part of the Inpatient Prospective Pay-for-Performance (IPPS) since 2013 Utilizes NHSN LabID surveillance definitions to lessen the surveillance burden and minimize chart review of clinical symptoms Background

Determine the extent of potential overreporting of Hospital Onset-C Determine the extent of potential overreporting of Hospital Onset-C.Difficile Infection (HO-CDI) using LabID criteria. Objective

Sample: Patients 18+ identified as HO-CDI per NHSN LabID criteria in a 1-year period (212 cases) Setting: Large, urban medical center in New York City Methods

Methods Study protocol Descriptive statistics recorded using retrospective chart review Symptoms of fever, abdominal pain, diarrhea Timing and duration of symptoms Alternative causes of loose stool (i.e., tube feeding, GI bleeds, inflammatory bowel disease, chemotherapy) Past positive results from outside facilities MAR- stool softeners/laxative administration within 24 hours of testing Antibiotic treatment of CDI (metronidazole, vancomycin, fidaxomicin) Methods

Patients were categorized into 1 of 6 clinical surveillance groups Methods

Findings 24% (n=51) probable HO-CDI 38.2% (n=81) possible HO-CDI 18.4% (n=39) colonized with self-limited symptoms 1.9% (n=4) asymptomatic colonizer 2.8% (n=2) relapse 14.6% (n=31) community acquired

34.4% (n=73) received stool softeners/ laxatives within 24 hours of testing 99% (n=210) received antimicrobial treatment for CDI Findings 100% of colonized (n=39) and 75% of asymptomatic colonized (n=3) treated

Discussion Overreporting Only 62.2% of hospital onset cases reported to NHSN were found to align with the clinical picture (categorized as probable or possible HO-CDI) Misclassifications thought to be due to delays in testing, inappropriate testing, and/or administration of stool softener/laxatives PCR testing widely used and unable to distinguish active infection from colonization NHSN surveillance definitions do not address the complicated clinical scenarios that can lead to misclassification of active infection Discussion 59.4% of NY Hospitals used PCR alone for CDI testing in 2015, 3% increase from previous yr

Discussion Overdiagnosis 34.1% of reported cases used stool softeners/laxatives shortly before testing Are clinicians aware of recent administration and/or PCR testing sensitivity? Discussion

Discussion Overtreatment Positive test results led to liberal treatment of the patient despite possibility of colonization Antibiotic treatment of colonized patients is NOT a recommended practice and could lead to the development of MDROs Discussion

Discussion Recommendations Electronic systems to guide testing practices may provide benefit ordering providers Further studies are needed to validate clinical criteria and improve the accuracy of HO-CDI surveillance Surveillance definitions could be improved by incorporating clinical criteria, but must be balanced against the labor intensive data collection processes Discussion

Evaluation Limitations Retrospective chart review , inconsistencies and challenges with documentation of symptoms One site, sample sicker than the general population Pediatric population not represented despite being recognized as a growing problem Evaluation Level III- non-experimental study B- consistent results, gateway for further study Evaluation

Evaluation

Thank you!